Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136


Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS.

Legriel S, Pico F, Tran-Dinh YR, Lemiale V, Bedos JP, Resche-Rigon M, Cariou A.

Ann Intensive Care. 2016 Dec;6(1):54. doi: 10.1186/s13613-016-0159-z. Epub 2016 Jun 21. Review.


Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.

Sié P.

Drug Des Devel Ther. 2016 May 18;10:1683-9. doi: 10.2147/DDDT.S94167. eCollection 2016. Review.


Timing of Occurrence Is the Most Important Characteristic of Spot Sign.

Wang B, Yan S, Xu M, Zhang S, Liu K, Hu H, Selim M, Lou M.

Stroke. 2016 May;47(5):1233-8. doi: 10.1161/STROKEAHA.116.012697. Epub 2016 Mar 29.


Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Ghadimi K, Levy JH, Welsby IJ.

Anesth Analg. 2016 May;122(5):1287-300. doi: 10.1213/ANE.0000000000001188.


Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time.

Dowlatshahi D, Brouwers HB, Demchuk AM, Hill MD, Aviv RI, Ufholz LA, Reaume M, Wintermark M, Hemphill JC 3rd, Murai Y, Wang Y, Zhao X, Wang Y, Li N, Sorimachi T, Matsumae M, Steiner T, Rizos T, Greenberg SM, Romero JM, Rosand J, Goldstein JN, Sharma M.

Stroke. 2016 Mar;47(3):695-700. doi: 10.1161/STROKEAHA.115.012012. Epub 2016 Feb 4. Review.


CT Angiography Spot Sign, Hematoma Expansion, and Outcome in Primary Pontine Intracerebral Hemorrhage.

Morotti A, Jessel MJ, Brouwers HB, Falcone GJ, Schwab K, Ayres AM, Vashkevich A, Anderson CD, Viswanathan A, Greenberg SM, Gurol ME, Romero JM, Rosand J, Goldstein JN.

Neurocrit Care. 2016 Aug;25(1):79-85. doi: 10.1007/s12028-016-0241-2.


Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Vaglio S, Prisco D, Biancofiore G, Rafanelli D, Antonioli P, Lisanti M, Andreani L, Basso L, Velati C, Grazzini G, Liumbruno GM.

Blood Transfus. 2016 Jan;14(1):23-65. doi: 10.2450/2015.0172-15. Epub 2015 Dec 15. No abstract available.


Surgery versus Conservative Treatment for Spontaneous Supratentorial Intracerebral Hemorrhage in Spot Sign Positive Patients.

Kim HT, Lee JM, Koh EJ, Choi HY.

J Korean Neurosurg Soc. 2015 Oct;58(4):309-15. doi: 10.3340/jkns.2015.58.4.309. Epub 2015 Oct 30.


Reversal Strategies for Intracranial Hemorrhages in Patients Taking Oral Factor Xa Inhibitors.

Karli B, Bartel B, Pavelko R.

Hosp Pharm. 2015 Jul;50(7):569-77. doi: 10.1310/hpj5007-569. Epub 2015 Jul 31.


Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage.

Brouwers HB, Battey TW, Musial HH, Ciura VA, Falcone GJ, Ayres AM, Vashkevich A, Schwab K, Viswanathan A, Anderson CD, Greenberg SM, Pomerantz SR, Ortiz CJ, Goldstein JN, Gonzalez RG, Rosand J, Romero JM.

Stroke. 2015 Sep;46(9):2498-503. doi: 10.1161/STROKEAHA.115.009659. Epub 2015 Aug 4.


Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis.

Yaghi S, Haggiagi A, Sherzai A, Marshall RS, Agarwal S.

Clin Pract. 2015 Jun 18;5(2):756. doi: 10.4081/cp.2015.756. eCollection 2015 Apr 24.


Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis.

Li HQ, Wei JJ, Xia W, Li JH, Liu AJ, Yin SB, Wang C, Song L, Wang Y, Zheng GQ, Fan JP.

Acta Pharmacol Sin. 2015 Jun;36(6):659-75. doi: 10.1038/aps.2014.139. Epub 2015 May 11. Review.


Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage.

Klebe D, McBride D, Flores JJ, Zhang JH, Tang J.

J Neuroimmune Pharmacol. 2015 Dec;10(4):576-86. doi: 10.1007/s11481-015-9613-1. Epub 2015 May 7.


Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery.

Leclerc JL, Lampert AS, Diller MA, Immergluck JB, Doré S.

ASN Neuro. 2015 Apr 13;7(2). pii: 1759091415578713. doi: 10.1177/1759091415578713. Print 2015 Mar-Apr.


Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage.

Leclerc JL, Lampert AS, Diller MA, Doré S.

Eur J Neurosci. 2015 May;41(10):1381-91. doi: 10.1111/ejn.12909.


Full medical support for intracerebral hemorrhage.

Morgenstern LB, Zahuranec DB, Sánchez BN, Becker KJ, Geraghty M, Hughes R, Norris G, Hemphill JC 3rd.

Neurology. 2015 Apr 28;84(17):1739-44. doi: 10.1212/WNL.0000000000001525. Epub 2015 Mar 27.


Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.

Pemmaraju N, Sasaki K, Johnson D, Daver N, Afshar-Kharghan V, Chen M, Ahmed S, Colen RR, Kwon M, Huh Y, Borthakur G.

Front Oncol. 2015 Feb 11;5:29. doi: 10.3389/fonc.2015.00029. eCollection 2015.


Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.

Esper RC, Estrada IE, de la Torre León T, Gutiérrez AO, López JA.

J Intensive Care. 2014 Aug 27;2(1):47. doi: 10.1186/s40560-014-0047-2. eCollection 2014.


Time course and predictors of neurological deterioration after intracerebral hemorrhage.

Lord AS, Gilmore E, Choi HA, Mayer SA; VISTA-ICH Collaboration.

Stroke. 2015 Mar;46(3):647-52. doi: 10.1161/STROKEAHA.114.007704. Epub 2015 Feb 5.


Ischemic stroke detection system with a computer-aided diagnostic ability using an unsupervised feature perception enhancement method.

Tyan YS, Wu MC, Chin CL, Kuo YL, Lee MS, Chang HY.

Int J Biomed Imaging. 2014;2014:947539. doi: 10.1155/2014/947539. Epub 2014 Dec 9.

Items per page

Supplemental Content

Write to the Help Desk